Syncromune
Phase 2Syncromune® is developing SYNC-T®, a platform immunotherapy designed to synchronize the location of 3 key components needed to educate the immune system to recognize and attack cancer. Now enrolling LEGION-100 trial for metastatic castration-resistant prostate cancer. www.legion100trial.com
Founded
2020
Focus
OncologyImmunologyCell Therapy
About
Syncromune® is developing SYNC-T®, a platform immunotherapy designed to synchronize the location of 3 key components needed to educate the immune system to recognize and attack cancer. Now enrolling LEGION-100 trial for metastatic castration-resistant prostate cancer. www.legion100trial.com
Funding History
1Total raised: $5M
Seed$5MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2020
LocationBoca Raton, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile